LA JOLLA, Calif., May 12 TorreyPinesTherapeutics, Inc. (Nasdaq: TPTX) today announced that the company willconduct a conference call and audio webcast on Tuesday, May 13, 2008 at11:00 a.m., Eastern Time (ET), in conjunction with the release of itsfinancial results for the first quarter ended March 31, 2008. TorreyPinesanticipates releasing its financial results at 7:30 a.m. ET on Tuesday,May 13, 2008.
To participate in this conference call, dial 719-325-4817, confirmationcode 2644321 shortly before 11:00 a.m. ET. A replay of the call will beavailable from 2:00 p.m. ET. The replay number is 719-457-0820, confirmationcode 2644321. The audio webcast can be accessed at:http://www.torreypinestherapeutics.com.
About TorreyPines Therapeutics
TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed toproviding patients with better alternatives to existing therapies through theresearch, development and commercialization of small molecule compounds. Thecompany's goal is to develop versatile product candidates each capable oftreating a number of acute and chronic diseases and disorders such asmigraine, chronic pain, muscle spasticity and rigidity, xerostomia andcognitive disorders. The company is currently developing four productcandidates: two ionotropic glutamate receptor antagonists and two muscarinicreceptor agonists. Further information is available athttp://www.torreypinestherapeutics.com.Company Contact: Media Contact: Craig Johnson David Schull TorreyPines Therapeutics, Inc. Russo Partners, LLC 858-623-5665, x118 212-845-4271 email@example.com firstname.lastname@example.org Investor Contact: Rhonda Chiger Rx Communications 917-322-2569 email@example.com
SOURCE TorreyPines Therapeutics, Inc.